公开(公告)号：US20100099633A1

公开(公告)日：2010-04-22

申请号：US12424193

申请日：2009-04-15

Applicant: Hang-Ching Lin ,  Wen-Liang Chang ,  Tsu-Chung Chang ,  Hsiou-Yu Ding ,  Tian Shung Wu

Inventor： Hang-Ching Lin ,  Wen-Liang Chang ,  Tsu-Chung Chang ,  Hsiou-Yu Ding ,  Tian Shung Wu

IPC: A61K31/7048 ,  A61P1/00 ,  A61P3/02

CPC classification number: A61K31/704 ,  A61K36/481 ,  Y10S514/909 ,  Y10S514/923

Abstract: The present application relates to a method for enhancing absorption of a nutrient in a subject in need thereof with an effective amount of an isolated astragaloside compound.

Abstract translation: 本申请涉及一种用有效量的分离的黄芪甲苷化合物增强有需要的受试者的营养素吸收的方法。

公开(公告)号：US20090318399A1

公开(公告)日：2009-12-24

申请号：US12473110

申请日：2009-05-27

Applicant: Hang-Ching Lin ,  Wen-Mein Wu

Inventor： Hang-Ching Lin ,  Wen-Mein Wu

IPC: A61K31/56

CPC classification number: A61K31/56 ,  A61K36/076

Abstract: The present invention discloses a novel use of a lanostane having the following formula (I) in treating a disease induced from immune disorder: wherein R1 is either H or CH3; R2 is OCOCH3, ═O or OH; R3 is H or OH; R4 is —C(═CH2)—C(CH3)2Ra, in which Ra is H or OH, or —CH═C(CH3)—Rb, in which Rb is CH3 or CH2OH; R5 is H or OH; and R6 is CH3 or CH2OH.

Abstract translation: 本发明公开了具有下式（I）的羊毛甾醇在治疗由免疫疾病诱导的疾病中的新用途：其中R1是H或CH3; R2是OCOCH3，-O或OH; R3是H或OH; R4是-C（-CH2）-C（CH3）2Ra，其中Ra是H或OH，或-CH-C（CH3）-Rb，其中Rb是CH3或CH2OH; R5是H或OH; 并且R 6是CH 3或CH 2 OH。

公开(公告)号：US20060292251A1

公开(公告)日：2006-12-28

申请号：US11426029

申请日：2006-06-23

Applicant: Hang-Ching LIN ,  Wen-Liang CHANG ,  Tsu-Chung CHANG ,  Hsiou-Yu DING ,  Tian WU

Inventor： Hang-Ching LIN ,  Wen-Liang CHANG ,  Tsu-Chung CHANG ,  Hsiou-Yu DING ,  Tian WU

IPC: A61K36/482 ,  A61K31/56 ,  A61K36/48 ,  A61K31/704

CPC classification number: A61K31/704 ,  A61K36/258 ,  A61K36/481

Abstract: There is provided a method for enhancing the absorption of a nutrient in a subject, including administering to the subject an effective amount of a astragaloside compound purified from Astragalus membranaceus var. mongholicus for facilitating transportation of the nutrient across gut cells of the subject.

Abstract translation: 本发明提供一种增强受试者营养素吸收的方法，包括向受试者施用有效量的从黄芪变种纯化的黄芪甲苷化合物。 促进营养物质通过受试者肠道细胞的运输。

公开(公告)号：US20050256208A1

公开(公告)日：2005-11-17

申请号：US11126225

申请日：2005-05-11

Applicant: Hang-Ching Lin ,  Hsiou-Yu Ding ,  Wen-Liang Chang ,  Chien-Lian Chao ,  Hsin-Wen Huang

Inventor： Hang-Ching Lin ,  Hsiou-Yu Ding ,  Wen-Liang Chang ,  Chien-Lian Chao ,  Hsin-Wen Huang

IPC: A61K36/899 ,  A61K31/05 ,  A61K36/00 ,  A61P19/10 ,  A61P35/00

CPC classification number: A61K31/05

Abstract: The present invention discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering breast cancer. An embodiment of this novel use is a pharmaceutical composition containing bakuchiol or an extract containing bakuchiol, which can be in the dosage forms of topical use, oral administration, injection or sustained release. The present invention also discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering osteoporosis.

Abstract translation: 本发明公开了一种用于预防或治疗患有乳腺癌的女性的bakuchiol或含有bakuchiol的提取物的新用途。 这种新用途的一个实施方案是含有bakuchiol或含有bakuchiol的提取物的药物组合物，其可以是局部使用，口服给药，注射或持续释放的剂型。 本发明还公开了一种新颖的使用bakuchiol或含有bakuchiol的提取物来预防或治疗患有骨质疏松症的女性。

公开(公告)号：US08658629B2

公开(公告)日：2014-02-25

申请号：US12771777

申请日：2010-04-30

Applicant: Hang-Ching Lin

Inventor： Hang-Ching Lin

IPC: A61K31/56

CPC classification number: A61K9/1652 ,  A61K9/4866 ,  A61K31/575 ,  A61K36/076

Abstract: A pharmaceutical composition for treating cachexia, and in particular for treating cancer cachexia. The composition contains a lanostane compound as a potent component. A suitable source of the lanostane compound is a Poria extract from metabolite, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The Poria extract contains 1-60% of the lanostane compounds by weight of the extract, and is devoid of secolanostane.

Abstract translation: 用于治疗恶病质，特别是用于治疗恶病质的药物组合物。 该组合物含有羊毛甾醇化合物作为有效成分。 羊毛甾烷化合物的合适来源是茯苓（Schw）狼的代谢物，菌核或发酵产物的茯苓提取物。 茯苓提取物含有1-60％的羊毛甾烷化合物，其重量为提取物，并且没有塞可安烷。

公开(公告)号：US08168596B2

公开(公告)日：2012-05-01

申请号：US12253779

申请日：2008-10-17

Applicant: Wen-Liang Chang ,  Tsu-Chung Chang ,  Hang-Ching Lin ,  Yuan Yang ,  Shu-Fen Huang

Inventor： Wen-Liang Chang ,  Tsu-Chung Chang ,  Hang-Ching Lin ,  Yuan Yang ,  Shu-Fen Huang

IPC: A61K31/56 ,  A01N45/00

CPC classification number: A61K31/704 ,  A61K9/0019

Abstract: A method of treating a disease associated with cartilage defect in a subject in need thereof by administering to the subject an effectively amount of a cycloartane compound of Formula (I).

Abstract translation: 一种通过向受试者施用有效量的式（I）的环加烷化合物来治疗有需要的受试者与软骨缺损相关的疾病的方法。

公开(公告)号：US20110053899A1

公开(公告)日：2011-03-03

申请号：US12854037

申请日：2010-08-10

Applicant: Hang-Ching Lin ,  Yu-Chuan Huang ,  Tsu-Chung Chang ,  Wen-Liang Chang

Inventor： Hang-Ching Lin ,  Yu-Chuan Huang ,  Tsu-Chung Chang ,  Wen-Liang Chang

IPC: A61K31/575 ,  A61P3/10

CPC classification number: A61K31/575 ,  A61K36/076

Abstract: A pharmaceutical composition for treating diabetes is provided in this invention. The composition contains a lanostane compound as a potent component. A suitable source of the lanostane compound is a Poria extract from metabolite, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The Poria extract contains 1-60% of the lanostane compounds by weight of the extract, and is devoid of secolanostane.

Abstract translation: 本发明提供了用于治疗糖尿病的药物组合物。 组合物含有作为有效成分的羊毛甾醇化合物。 羊毛甾烷化合物的合适来源是茯苓（Schw）狼的代谢物，菌核或发酵产物的茯苓提取物。 茯苓提取物含有1-60％的羊毛甾烷化合物，其重量为提取物，并且没有塞可安烷。

公开(公告)号：US07714026B2

公开(公告)日：2010-05-11

申请号：US11126234

申请日：2005-05-11

Applicant: Hang-Ching Lin ,  Hsiou-Yu Ding ,  Wen-Liang Chang ,  Chien-Lian Chao ,  Hsin-Wen Huang ,  Chin-Liang Lin

Inventor： Hang-Ching Lin ,  Hsiou-Yu Ding ,  Wen-Liang Chang ,  Chien-Lian Chao ,  Hsin-Wen Huang ,  Chin-Liang Lin

IPC: A61K31/05

CPC classification number: A61K31/05

Abstract: The present invention discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering osteoporosis. An embodiment of this novel use is a pharmaceutical composition containing bakuchiol or an extract containing bakuchiol, which can be in the dosage forms of topical use, oral administration, injection or sustained release. The present invention also discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering breast cancer.

Abstract translation: 本发明公开了一种用于预防或治疗患有骨质疏松症的女性的bakuchiol或含有bakuchiol的提取物的新用途。 这种新用途的一个实施方案是含有bakuchiol或含有bakuchiol的提取物的药物组合物，其可以是局部使用，口服给药，注射或持续释放的剂型。 本发明还公开了一种新颖的使用bakuchiol或含有bakuchiol的提取物来预防或治疗患有乳腺癌的女性。

公开(公告)号：US20090181904A1

公开(公告)日：2009-07-16

申请号：US12345218

申请日：2008-12-29

Applicant: Hang-Ching Lin ,  Wen- Liang Chang ,  Tsu-Chung Chang ,  Hsiou-Yu Ding ,  Tian Shung Wu

Inventor： Hang-Ching Lin ,  Wen- Liang Chang ,  Tsu-Chung Chang ,  Hsiou-Yu Ding ,  Tian Shung Wu

IPC: A61K31/704 ,  A61K31/575 ,  A61P1/00 ,  A61P3/00

CPC classification number: A61K31/575 ,  A61K31/704

Abstract: The present application relates to a method of regulating nutrient absorption in a subject in need thereof with an isolated ginsenoside compound.

Abstract translation: 本申请涉及使用分离的人参皂甙化合物调节有需要的受试者的营养吸收的方法。

公开(公告)号：US20060293255A1

公开(公告)日：2006-12-28

申请号：US11426064

申请日：2006-06-23

Applicant: Hang-Ching LIN ,  Wen-Liang CHANG ,  Tsu-Chung CHANG ,  Hsiou-Yu DING ,  Tian WU

Inventor： Hang-Ching LIN ,  Wen-Liang CHANG ,  Tsu-Chung CHANG ,  Hsiou-Yu DING ,  Tian WU

IPC: A61K31/704

CPC classification number: A61K31/704 ,  A61K36/258 ,  A61K36/481

Abstract: There is provided a method for regulating the absorption of a nutrient in a subject, including administering to the subject an effective amount of a ginsenoside compound purified from Panax notoginseng for modulating transportation of the nutrient across gut cells of the subject.

Abstract translation: 提供了调节受试者的营养素的吸收的方法，包括向受试者施用有效量的人参皂甙化合物，其从三七总皂苷纯化，用于调节营养物质在受试者的肠道细胞中的运输。